1
|
Boubour A, Kim CY, Torres S, Jia DT, Hess E, Liu S, Sun Y, Fong K, Epstein S, Yan H, Luche N, Gao K, Glassberg B, Harmon M, Hoang H, Navis A, Schorr E, Gofshteyn JS, Yeshokumar AK, Thakur KT. Sociodemographic and Clinical Factors Associated With Clinical Outcome in Neuroinfectious Diseases: A Multicenter Retrospective Cohort Study. Neurohospitalist 2024; 14:396-405. [PMID: 39308466 PMCID: PMC11412469 DOI: 10.1177/19418744241263138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/25/2024] Open
Abstract
Objective To evaluate sociodemographic and clinical factors associated with clinical outcomes in patients hospitalized with neuroinfectious diseases at three tertiary care centers in New York City. Methods This retrospective cohort study was conducted at three large urban tertiary care centers between January 1, 2010 and December 31, 2017. Poor clinical outcome was defined as length of hospital stay (LOS) ≥2 weeks and/or discharge to a location other than home. Sociodemographic and clinical factors were obtained from electronic medical records and descriptively analyzed. Multivariate logistic regression analysis investigated relationships between sociodemographic and clinical factors, and outcomes. Results Among 205 patients with definitive neuroinfectious diagnoses, older patients were more likely to have a LOS ≥2 weeks (odds ratio [OR]: 1.03; 95% confidence interval [CI]: 1.01-1.05) and less likely to be discharged home (OR: 0.96; 95% CI: 0.94-0.98) than younger patients. Patients with an immunocompromised state were more likely to have a LOS ≥2 weeks (OR: 2.80; 95% CI: 1.17-6.69). Additionally, patients admitted to the intensive care unit (ICU) were more likely to have a LOS ≥2 weeks (OR: 4.65; 95% CI: 2.13-10.16) and less likely to be discharged home (OR: 0.14; 95% CI: 0.06-0.34). There were no statistically significant associations between sex, race, ethnicity, English proficiency, substance use, or poverty index, and clinical outcome. Conclusions In this multicenter cohort of hospitalized neuroinfectious diseases, older age, history of immunocompromised state, and admission to the ICU were significantly associated with poor clinical outcome.
Collapse
Affiliation(s)
- Alexandra Boubour
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
| | - Carla Y. Kim
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
| | - Sarah Torres
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
| | - Dan T. Jia
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
| | - Evan Hess
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
| | - Sibei Liu
- Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA
| | - Yifei Sun
- Department of Biostatistics, Columbia University Mailman School of Public Health, New York, NY, USA
| | - Kathryn Fong
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
- Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY USA
| | - Samantha Epstein
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
- Multiple Sclerosis Center, Columbia University Irving Medical Center, New York, NY USA
| | - Helena Yan
- Department of Pediatrics, Weill Cornell Medical Center, New York, NY, USA
| | - Nicole Luche
- Department of Pediatrics, Weill Cornell Medical Center, New York, NY, USA
| | - Kerry Gao
- Department of Pediatrics, Weill Cornell Medical Center, New York, NY, USA
| | - Brittany Glassberg
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Michael Harmon
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Hai Hoang
- Department of Pediatrics, Weill Cornell Medical Center, New York, NY, USA
| | - Allison Navis
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Emily Schorr
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - Anusha K. Yeshokumar
- Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Kiran T. Thakur
- Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA
| |
Collapse
|
2
|
Ramachandran PS, Ramesh A, Creswell FV, Wapniarski A, Narendra R, Quinn CM, Tran EB, Rutakingirwa MK, Bangdiwala AS, Kagimu E, Kandole KT, Zorn KC, Tugume L, Kasibante J, Ssebambulidde K, Okirwoth M, Bahr NC, Musubire A, Skipper CP, Fouassier C, Lyden A, Serpa P, Castaneda G, Caldera S, Ahyong V, DeRisi JL, Langelier C, Crawford ED, Boulware DR, Meya DB, Wilson MR. Integrating central nervous system metagenomics and host response for diagnosis of tuberculosis meningitis and its mimics. Nat Commun 2022; 13:1675. [PMID: 35354815 PMCID: PMC8967864 DOI: 10.1038/s41467-022-29353-x] [Citation(s) in RCA: 32] [Impact Index Per Article: 16.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2021] [Accepted: 03/11/2022] [Indexed: 12/13/2022] Open
Abstract
The epidemiology of infectious causes of meningitis in sub-Saharan Africa is not well understood, and a common cause of meningitis in this region, Mycobacterium tuberculosis (TB), is notoriously hard to diagnose. Here we show that integrating cerebrospinal fluid (CSF) metagenomic next-generation sequencing (mNGS) with a host gene expression-based machine learning classifier (MLC) enhances diagnostic accuracy for TB meningitis (TBM) and its mimics. 368 HIV-infected Ugandan adults with subacute meningitis were prospectively enrolled. Total RNA and DNA CSF mNGS libraries were sequenced to identify meningitis pathogens. In parallel, a CSF host transcriptomic MLC to distinguish between TBM and other infections was trained and then evaluated in a blinded fashion on an independent dataset. mNGS identifies an array of infectious TBM mimics (and co-infections), including emerging, treatable, and vaccine-preventable pathogens including Wesselsbron virus, Toxoplasma gondii, Streptococcus pneumoniae, Nocardia brasiliensis, measles virus and cytomegalovirus. By leveraging the specificity of mNGS and the sensitivity of an MLC created from CSF host transcriptomes, the combined assay has high sensitivity (88.9%) and specificity (86.7%) for the detection of TBM and its many mimics. Furthermore, we achieve comparable combined assay performance at sequencing depths more amenable to performing diagnostic mNGS in low resource settings.
Collapse
Affiliation(s)
- P S Ramachandran
- Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
- University of Melbourne, Melbourne, VIC, Australia
- UCSF Center for Tuberculosis, San Francisco, CA, USA
- UCSF Center for Encephalitis and Meningitis, San Francisco, CA, USA
| | - A Ramesh
- Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
| | - F V Creswell
- Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
- Medical Research Council-Uganda Virus Research Institute-LSHTM Uganda Research Unit, Entebbe, Uganda
| | - A Wapniarski
- Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
| | - R Narendra
- Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
| | - C M Quinn
- University of California School of Medicine, San Francisco, CA, USA
| | - E B Tran
- University of California School of Medicine, San Francisco, CA, USA
| | - M K Rutakingirwa
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | | | - E Kagimu
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | - K T Kandole
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | - K C Zorn
- UCSF Center for Encephalitis and Meningitis, San Francisco, CA, USA
- Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA
| | - L Tugume
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | - J Kasibante
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | - K Ssebambulidde
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | - M Okirwoth
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | - N C Bahr
- Division of Infectious Diseases, Department of Medicine, University of Kansas, Kansas City, KS, USA
| | - A Musubire
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
| | - C P Skipper
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
- University of Minnesota, Minneapolis, MN, USA
| | - C Fouassier
- Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA
| | - A Lyden
- Chan Zuckerberg Biohub, San Francisco, CA, USA
| | - P Serpa
- Chan Zuckerberg Biohub, San Francisco, CA, USA
| | - G Castaneda
- Chan Zuckerberg Biohub, San Francisco, CA, USA
| | - S Caldera
- Chan Zuckerberg Biohub, San Francisco, CA, USA
| | - V Ahyong
- Chan Zuckerberg Biohub, San Francisco, CA, USA
| | - J L DeRisi
- UCSF Center for Encephalitis and Meningitis, San Francisco, CA, USA
- Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA
- Chan Zuckerberg Biohub, San Francisco, CA, USA
| | - C Langelier
- Chan Zuckerberg Biohub, San Francisco, CA, USA
- Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
| | | | | | - D B Meya
- Infectious Diseases Institute, Makerere University, Kampala, Uganda
- University of Minnesota, Minneapolis, MN, USA
| | - M R Wilson
- Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
- UCSF Center for Tuberculosis, San Francisco, CA, USA.
- UCSF Center for Encephalitis and Meningitis, San Francisco, CA, USA.
| |
Collapse
|